-
2-((3-(4-Methoxyphenyl)-4-oxo-3,4,5,6,7,8-hexahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)acetonitrile
-
BD01178724337349-54-997%
-
¥1904.025mg
-
1-Methyl-3-(1-methyl-1H-indol-3-yl)-4-(pentylamino)-1H-pyrrole-2,5-dione
-
BD341752861891-50-199%
-
¥219.01mg
-
(2R,3R,4S,5R,6S)-2-(Hydroxymethyl)-6-(2-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triol
-
BD20488369-07-397%
-
¥32.01g
-
3,7-Dimethyloct-6-en-1-ol
-
BD121827106-22-995+%
-
¥135.0500g
-
Necroptosis-IN-1
-
BD012889921391980-92-998%
-
¥993.05mg
-
5-((3-(4-Fluorophenyl)-1H-pyrazol-4-yl)methylene)-2-imino-3-(thiazol-2-yl)thiazolidin-4-one
-
BD682963351062-08-398%
-
¥5572.0100mg
-
N-(Thiophen-2-ylmethyl)cyclohexanecarboxamide
-
BD01166437547698-18-098%
-
¥1223.010mg
-
Methyl (7bR,8aS)-4-oxo-2-(5,6,7-trimethoxy-1H-indole-2-carbonyl)-1,2,4,5,8,8a-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-6-carboxylate
-
BD766905130288-24-398%
-
¥
-
RIPK1-IN-12
-
BD015154282173556-92-698%
-
¥
-
RIP1/RIP3/MLKL activator 1
-
BD015370132682850-41-398%
-
¥
-
Antiparasitic agent-15
-
BD0230966098%
-
¥
-
MLKL-IN-4
-
BD023329783031406-17-198%
-
¥
-
RX-3117
-
BD434991865838-26-298+%
-
¥
-
3',6'-Dihydroxy-6-isothiocyanato-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one
-
BD24677918861-78-490%
-
¥657.0100mg
-
Antiparasitic agent-16
-
BD0232815098%
-
¥
-
NSC10010 dihydrochloride
-
BD025294746286-09-598%
-
¥
-
Anticancer agent 118
-
BD02214576864443-43-698%
-
¥
-
Pectic acid
-
BD011072959046-40-6
-
¥
-
1-(3-((((2R,3S,4R,5R)-5-(4-Amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea hydrochloride
-
BD2630241380316-03-998+%
-
¥4949.010mg
-
KWCN-41
-
BD021299512913223-17-198%
-
¥